JZP-361

• Description:

  JZP-361 is a specific MAGL inhibitor with IC50s of 46 nM, 7.24 μM, and 1.79 μM for human recombinant MAGL, human recombinant FAAH, and human hABHD6. JZP-361 displays anti-histaminergic activities. JZP-361 can be used in studies about asthma.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  405.88

• Molecular Formula:

  C22H20ClN5O

• Notes:

  Research use only, not for human use.

• Receptor:

  Lipase

• CAS Number:

  1680193-80-9